BACKGROUND: Non-adherence to cardiovascular medications is a problem worldwide, even in Australia, which has a socialized medical system, Medicare. OBJECTIVE: The aim of this systematic review was to evaluate the burden of non-adherence to cardiovascular medications and factors thereof in Australia. DATA SOURCES: Pubmed, Embase, CINAHL, PsycInfo, Cochrane Library databases were searched. ELIGIBILITY CRITERIA: Articles were included if they were in English, peer-reviewed and provided empirical data on adherence to cardiovascular medication for an Australian cohort. METHODS: A meta-analysis of prevalence of medication non-adherence using the double arcsine square root transformed proportion was undertaken. Studies were pooled in homogenous prevalence groups and factors that differed across groups were ascertained. RESULTS: Five studies, including eight datasets and 76,867 subjects were analyzed. Three more or less homogenous prevalence categories were discernable: low [19 %, 95 % confidence interval (CI) 15-24], moderate (26 %, 95 % CI 23-29) and high (43 %, 95 % CI 43-44; this was a single study) prevalence of non-adherence. There were minimal clear patterns across groups in relation to typical factors of non-adherence (patient, condition, healthcare system or socioeconomic factors). Measurements used for non-adherence were similar for six of the eight included datasets, suggesting this did not affect prevalence of non-adherence or inclusion in a prevalence group. CONCLUSIONS: Non-adherence to cardiovascular medications is a serious problem in the aging Australian setting with an overall prevalence of between 14 and 43 %. The lack of patterns in the typical factors of non-adherence suggests that another factor, such as patients' beliefs about their conditions and medications, may be playing a stronger role in their non-adherence than clinical or sociodemographic factors. This is an area for further research.
BACKGROUND: Non-adherence to cardiovascular medications is a problem worldwide, even in Australia, which has a socialized medical system, Medicare. OBJECTIVE: The aim of this systematic review was to evaluate the burden of non-adherence to cardiovascular medications and factors thereof in Australia. DATA SOURCES: Pubmed, Embase, CINAHL, PsycInfo, Cochrane Library databases were searched. ELIGIBILITY CRITERIA: Articles were included if they were in English, peer-reviewed and provided empirical data on adherence to cardiovascular medication for an Australian cohort. METHODS: A meta-analysis of prevalence of medication non-adherence using the double arcsine square root transformed proportion was undertaken. Studies were pooled in homogenous prevalence groups and factors that differed across groups were ascertained. RESULTS: Five studies, including eight datasets and 76,867 subjects were analyzed. Three more or less homogenous prevalence categories were discernable: low [19 %, 95 % confidence interval (CI) 15-24], moderate (26 %, 95 % CI 23-29) and high (43 %, 95 % CI 43-44; this was a single study) prevalence of non-adherence. There were minimal clear patterns across groups in relation to typical factors of non-adherence (patient, condition, healthcare system or socioeconomic factors). Measurements used for non-adherence were similar for six of the eight included datasets, suggesting this did not affect prevalence of non-adherence or inclusion in a prevalence group. CONCLUSIONS: Non-adherence to cardiovascular medications is a serious problem in the aging Australian setting with an overall prevalence of between 14 and 43 %. The lack of patterns in the typical factors of non-adherence suggests that another factor, such as patients' beliefs about their conditions and medications, may be playing a stronger role in their non-adherence than clinical or sociodemographic factors. This is an area for further research.
Authors: P Lindgren; J Eriksson; M Buxton; T Kahan; N R Poulter; B Dahlöf; P S Sever; H Wedel; B Jönsson Journal: Int J Clin Pract Date: 2010-05-24 Impact factor: 2.503
Authors: Ingar Holme; Michael Szarek; Nilo B Cater; Ole Faergeman; John J P Kastelein; Anders G Olsson; Matti J Tikkanen; Mogens Lytken Larsen; Christina Lindahl; Terje R Pedersen Journal: Eur J Cardiovasc Prev Rehabil Date: 2009-06
Authors: P Michael Ho; David J Magid; Frederick A Masoudi; David L McClure; John S Rumsfeld Journal: BMC Cardiovasc Disord Date: 2006-12-15 Impact factor: 2.298
Authors: Valery L Feigin; Bo Norrving; Mary G George; Jennifer L Foltz; Gregory A Roth; George A Mensah Journal: Nat Rev Neurol Date: 2016-07-22 Impact factor: 42.937
Authors: Martin Wawruch; Dusan Zatko; Gejza Wimmer; Jan Luha; Lenka Kuzelova; Peter Kukumberg; Jan Murin; Adam Hloska; Tomas Tesar; Zoltan Kallay; Rashmi Shah Journal: Drugs Aging Date: 2016-05 Impact factor: 3.923
Authors: Holly Tibble; James Lay-Flurrie; Aziz Sheikh; Rob Horne; Mehrdad A Mizani; Athanasios Tsanas Journal: BMC Med Res Methodol Date: 2020-12-10 Impact factor: 4.615
Authors: Bettina Habib; David Buckeridge; Melissa Bustillo; Santiago Nicolas Marquez; Manish Thakur; Thai Tran; Daniala L Weir; Robyn Tamblyn Journal: JAMIA Open Date: 2021-07-31
Authors: Karla Santo; Clara K Chow; Aravinda Thiagalingam; Kris Rogers; John Chalmers; Julie Redfern Journal: BMJ Open Date: 2017-10-08 Impact factor: 2.692